Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy.
about
The search for novel analgesics: targets and mechanismsTreatment of painful bladder syndrome/interstitial cystitis with botulinum toxin A: why isn't it effective in all patients?Current status and future directions of botulinum neurotoxins for targeting pain processingOnabotulinumtoxinA for trigeminal neuralgia: a review of the available dataBotulinum Toxin for Neuropathic Pain: A Review of the LiteratureBotulinum Toxin as a Pain Killer: Players and Actions in AntinociceptionBotulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?Therapeutic use of botulinum toxin in migraine: mechanisms of action.The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytesBotulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.Application of purified botulinum type a neurotoxin to treat experimental trigeminal neuropathy in rats and patients with urinary incontinence and prostatic hyperplasiaBotulinum toxin type A for neuropathic pain in patients with spinal cord injury.Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia.Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and AktGene therapy for trigeminal pain in mice.Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.Bilateral analgesic effects of abobotulinumtoxinA (Dysport® ) following unilateral administration in the rat.Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review.Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2.Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up.Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells.Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region.Direct central action of intramuscularly injected botulinum toxin: is it harmful or beneficial?Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats.Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain.Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region.Botulinum neurotoxin type-A when utilized in animals with trigeminal sensitization induced a antinociceptive effect.A Study and Review of Effects of Botulinum Toxins on Mast Cell Dependent and Independent Pruritus.The Expanding Therapeutic Utility of Botulinum Neurotoxins.Transcriptional Alterations in the Trigeminal Ganglia, Nucleus and Peripheral Blood Mononuclear Cells in a Rat Orofacial Pain Model.Botulinum toxin type A enhances the inhibitory spontaneous postsynaptic currents on the substantia gelatinosa neurons of the subnucleus caudalis in immature mice
P2860
Q24288817-AB8DE6B4-0AC1-4BC8-9819-4F93A569AEAFQ26773579-4C4AA626-72E5-480F-86BF-20B891FD144EQ26778129-6D7D9D80-A7FA-42F7-AEC7-A611A43CA4A8Q26796286-C1E4B2F9-9D35-45CB-8895-71DC88A5F9B7Q26796604-419054C3-8EEB-4867-94A7-BBD96C6DCD48Q28084583-D2B30F62-8F7C-413F-BC67-348D3E3E26AFQ34255178-C37EE646-85B2-4E20-91A9-A92B3E9BAA3BQ34419654-02BBF51D-D31C-42A3-9983-48FFAD78C90DQ34460791-6B711BC0-48E6-4B37-AA37-F7985D061678Q35691221-28F02A0E-459E-4886-9413-9326A7D963F9Q36056160-E23203B6-D8A4-475C-A884-742F658058BDQ36780108-44DA70D2-284A-41A3-8751-DB9399CACB89Q36788893-BC77E999-7CB1-4F03-B508-099A0BEC2AD1Q37062762-A7DDFDD2-DC4B-4D49-BBC0-A2B2E580232DQ37684630-8B6D26CE-4A35-4566-A903-DD579442DE87Q37686124-47269170-00B8-4547-811F-D15488CD0577Q38750238-C0B6ECB7-E934-4126-BC05-A2AE3718B13EQ38944196-CE75FCE4-3C48-48D0-9484-018D31E82DC4Q38998303-4D799B65-B5E8-41AF-979C-438D7D443F30Q40983059-1451D887-EA08-4B63-BC84-025979C0C615Q42283406-EEAFE6B8-8A03-4B03-AC7A-1E0CB7DE878EQ42838523-20058486-8EA2-4A74-A45F-BD75904D8C06Q44350809-819434AD-049C-4857-B2DF-EFE82FD680A5Q45755646-589DA020-D960-4E1B-9618-AD4AC726A235Q48470000-E2D7F71F-F58C-45F7-A75E-137458B0FDD4Q48579779-30A24A63-D232-4C58-A0C4-D1BC96B3363FQ50227033-D9C3E39F-7CE3-4BAB-8CC7-2319D7D75A98Q51688633-56578F30-E392-475D-86EF-861A59EE16AAQ52724685-54CFF04A-B4B5-49C5-A716-3D28BCDA9A89Q55105284-FE44B38E-72E2-412D-A55F-B6769F4533CFQ55689248-15B396E0-6D84-47EB-B65E-F1BB7C8A5461Q58700974-36D31B7A-F8FE-46EB-AD0E-CB6D54345755
P2860
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Central action of peripherally ...... odel of trigeminal neuropathy.
@ast
Central action of peripherally ...... odel of trigeminal neuropathy.
@en
Central action of peripherally ...... odel of trigeminal neuropathy.
@nl
type
label
Central action of peripherally ...... odel of trigeminal neuropathy.
@ast
Central action of peripherally ...... odel of trigeminal neuropathy.
@en
Central action of peripherally ...... odel of trigeminal neuropathy.
@nl
prefLabel
Central action of peripherally ...... odel of trigeminal neuropathy.
@ast
Central action of peripherally ...... odel of trigeminal neuropathy.
@en
Central action of peripherally ...... odel of trigeminal neuropathy.
@nl
P2093
P2860
P1433
P1476
Central action of peripherally ...... odel of trigeminal neuropathy.
@en
P2093
Boris Filipović
Ivica Matak
Lidija Bach-Rojecky
P2860
P304
P356
10.1371/JOURNAL.PONE.0029803
P407
P577
2012-01-04T00:00:00Z